|
@@ -0,0 +1,880 @@
|
|
|
+#LyX 2.3 created this file. For more info see http://www.lyx.org/
|
|
|
+\lyxformat 544
|
|
|
+\begin_document
|
|
|
+\begin_header
|
|
|
+\save_transient_properties true
|
|
|
+\origin unavailable
|
|
|
+\textclass extbook
|
|
|
+\begin_preamble
|
|
|
+\usepackage{fancyhdr}
|
|
|
+\pagestyle{fancy}
|
|
|
+\renewcommand{\headrulewidth}{0pt}
|
|
|
+\rhead{}
|
|
|
+\lhead{}
|
|
|
+\rfoot{}
|
|
|
+\lfoot{}
|
|
|
+\cfoot{\thepage}
|
|
|
+\usepackage{draftwatermark}
|
|
|
+\end_preamble
|
|
|
+\use_default_options true
|
|
|
+\maintain_unincluded_children false
|
|
|
+\language english
|
|
|
+\language_package default
|
|
|
+\inputencoding auto
|
|
|
+\fontencoding global
|
|
|
+\font_roman "default" "default"
|
|
|
+\font_sans "default" "default"
|
|
|
+\font_typewriter "default" "default"
|
|
|
+\font_math "auto" "auto"
|
|
|
+\font_default_family default
|
|
|
+\use_non_tex_fonts false
|
|
|
+\font_sc false
|
|
|
+\font_osf false
|
|
|
+\font_sf_scale 100 100
|
|
|
+\font_tt_scale 100 100
|
|
|
+\use_microtype false
|
|
|
+\use_dash_ligatures true
|
|
|
+\graphics default
|
|
|
+\default_output_format default
|
|
|
+\output_sync 0
|
|
|
+\bibtex_command default
|
|
|
+\index_command default
|
|
|
+\paperfontsize 12
|
|
|
+\spacing double
|
|
|
+\use_hyperref false
|
|
|
+\papersize letterpaper
|
|
|
+\use_geometry true
|
|
|
+\use_package amsmath 1
|
|
|
+\use_package amssymb 1
|
|
|
+\use_package cancel 1
|
|
|
+\use_package esint 1
|
|
|
+\use_package mathdots 1
|
|
|
+\use_package mathtools 1
|
|
|
+\use_package mhchem 1
|
|
|
+\use_package stackrel 1
|
|
|
+\use_package stmaryrd 1
|
|
|
+\use_package undertilde 1
|
|
|
+\cite_engine basic
|
|
|
+\cite_engine_type default
|
|
|
+\biblio_style plain
|
|
|
+\use_bibtopic false
|
|
|
+\use_indices false
|
|
|
+\paperorientation portrait
|
|
|
+\suppress_date false
|
|
|
+\justification true
|
|
|
+\use_refstyle 1
|
|
|
+\use_minted 0
|
|
|
+\index Index
|
|
|
+\shortcut idx
|
|
|
+\color #008000
|
|
|
+\end_index
|
|
|
+\leftmargin 1.5in
|
|
|
+\topmargin 1in
|
|
|
+\rightmargin 1in
|
|
|
+\bottommargin 1in
|
|
|
+\secnumdepth 3
|
|
|
+\tocdepth 3
|
|
|
+\paragraph_separation indent
|
|
|
+\paragraph_indentation default
|
|
|
+\is_math_indent 0
|
|
|
+\math_numbering_side default
|
|
|
+\quotes_style english
|
|
|
+\dynamic_quotes 0
|
|
|
+\papercolumns 1
|
|
|
+\papersides 2
|
|
|
+\paperpagestyle default
|
|
|
+\tracking_changes false
|
|
|
+\output_changes false
|
|
|
+\html_math_output 0
|
|
|
+\html_css_as_file 0
|
|
|
+\html_be_strict false
|
|
|
+\end_header
|
|
|
+
|
|
|
+\begin_body
|
|
|
+
|
|
|
+\begin_layout Title
|
|
|
+Bioinformatic analysis of complex, high-throughput genomic and epigenomic
|
|
|
+ data in the context of immunology and transplant rejection
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Author
|
|
|
+A thesis presented
|
|
|
+\begin_inset Newline newline
|
|
|
+\end_inset
|
|
|
+
|
|
|
+by
|
|
|
+\begin_inset Newline newline
|
|
|
+\end_inset
|
|
|
+
|
|
|
+ Ryan C.
|
|
|
+ Thompson
|
|
|
+\begin_inset Newline newline
|
|
|
+\end_inset
|
|
|
+
|
|
|
+ to
|
|
|
+\begin_inset Newline newline
|
|
|
+\end_inset
|
|
|
+
|
|
|
+ The Scripps Research Institute Graduate Program
|
|
|
+\begin_inset Newline newline
|
|
|
+\end_inset
|
|
|
+
|
|
|
+in partial fulfillment of the requirements for the degree of
|
|
|
+\begin_inset Newline newline
|
|
|
+\end_inset
|
|
|
+
|
|
|
+ Doctor of Philosophy in the subject of Biology
|
|
|
+\begin_inset Newline newline
|
|
|
+\end_inset
|
|
|
+
|
|
|
+ for
|
|
|
+\begin_inset Newline newline
|
|
|
+\end_inset
|
|
|
+
|
|
|
+ The Scripps Research Institute
|
|
|
+\begin_inset Newline newline
|
|
|
+\end_inset
|
|
|
+
|
|
|
+ La Jolla, California
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Date
|
|
|
+May 2019
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Standard
|
|
|
+[Copyright notice]
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Standard
|
|
|
+[Thesis acceptance form]
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Standard
|
|
|
+[Dedication]
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Standard
|
|
|
+[Acknowledgements]
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Standard
|
|
|
+[TOC]
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Standard
|
|
|
+[List of Tables]
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Standard
|
|
|
+[List of Figures]
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Standard
|
|
|
+[List of Abbreviations]
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Standard
|
|
|
+[Abstract]
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Chapter*
|
|
|
+Abstract
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Chapter*
|
|
|
+Introduction
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Section*
|
|
|
+Background & Significance
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Subsection*
|
|
|
+Biological motivation
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Rejection is the major long-term threat to organ and tissue grafts
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+Common mechanisms of rejection
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Effective immune suppression requires monitoring for rejection and tuning
|
|
|
+
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Current tests for rejection (tissue biopsy) are invasive and biased
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+A blood test based on microarrays would be less biased and invasive
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\end_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+Memory cells are resistant to immune suppression
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+Mechanisms of resistance in memory cells are poorly understood
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+A better understanding of immune memory formation is needed
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\end_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+Mesenchymal stem cell infusion is a promising new treatment to prevent/delay
|
|
|
+ rejection
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+Demonstrated in mice, but not yet in primates
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Mechanism currently unknown, but MSC are known to be immune modulatory
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\end_deeper
|
|
|
+\begin_layout Subsection*
|
|
|
+Overview of bioinformatic analysis methods
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Standard
|
|
|
+An overview of all the methods used, including what problem they solve,
|
|
|
+ what assumptions they make, and a basic description of how they work.
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+ChIP-seq Peak calling
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+Cross-correlation analysis to determine fragment size
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Broad vs narrow peaks
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+SICER for broad peaks
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+IDR for biologically reproducible peaks
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+csaw peak filtering guidelines for unbiased downstream analysis
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\end_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+Normalization is non-trivial and application-dependant
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+Expression arrays: RMA & fRMA; why fRMA is needed
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Methylation arrays: M-value transformation approximates normal data but
|
|
|
+ induces heteroskedasticity
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+RNA-seq: normalize based on assumption that the average gene is not changing
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+ChIP-seq: complex with many considerations, dependent on experimental methods,
|
|
|
+ biological system, and analysis goals
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\end_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+Limma: The standard linear modeling framework for genomics
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+empirical Bayes variance modeling: limma's core feature
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+edgeR & DESeq2: Extend with negative bonomial GLM for RNA-seq and other
|
|
|
+ count data
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+voom: Extend with precision weights to model mean-variance trend
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+arrayWeights and duplicateCorrelation to handle complex variance structures
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\end_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+sva and ComBat for batch correction
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Factor analysis: PCA, MDS, MOFA
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+Batch-corrected PCA is informative, but careful application is required
|
|
|
+ to avoid bias
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\end_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+Gene set analysis: camera and SPIA
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Section*
|
|
|
+Innovation
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+MSC infusion to improve transplant outcomes (prevent/delay rejection)
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+Characterize MSC response to interferon gamma
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+IFN-g is thought to stimulate their function
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Test IFN-g treated MSC infusion as a therapy to delay graft rejection in
|
|
|
+ cynomolgus monkeys
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Monitor animals post-transplant using blood RNA-seq at serial time points
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\end_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+Investigate dynamics of histone marks in CD4 T-cell activation and memory
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+Previous studies have looked at single snapshots of histone marks
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Instead, look at changes in histone marks across activation and memory
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\end_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+High-throughput sequencing and microarray technologies
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+Powerful methods for assaying gene expression and epigenetics across entire
|
|
|
+ genomes
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Proper analysis requires finding and exploiting systematic genome-wide trends
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\end_deeper
|
|
|
+\begin_layout Chapter*
|
|
|
+1.
|
|
|
+ Reproducible genome-wide epigenetic analysis of H3K4 and H3K27 methylation
|
|
|
+ in naive and memory CD4 T-cell activation
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Section*
|
|
|
+Approach
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+CD4 T-cells are central to all adaptive immune responses and memory
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+H3K4 and H3K27 methylation are major epigenetic regulators of gene expression
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Canonically, H3K4 is activating and H3K27 is inhibitory, but the reality
|
|
|
+ is complex
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Looking at these marks during CD4 activation and memory should reveal new
|
|
|
+ mechanistic details
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Test
|
|
|
+\begin_inset Quotes eld
|
|
|
+\end_inset
|
|
|
+
|
|
|
+poised promoter
|
|
|
+\begin_inset Quotes erd
|
|
|
+\end_inset
|
|
|
+
|
|
|
+ hypothesis in which H3K4 and H3K27 are both methylated
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Expand scope of analysis beyond simple promoter counts
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+Analyze peaks genome-wide, including in intergenic regions
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Analysis of coverage distribution shape within promoters, e.g.
|
|
|
+ upstream vs downstream coverage
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\end_deeper
|
|
|
+\begin_layout Section*
|
|
|
+Methods
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Re-analyze previously published CD4 ChIP-seq & RNA-seq data
|
|
|
+\begin_inset CommandInset citation
|
|
|
+LatexCommand cite
|
|
|
+key "LaMere2016,Lamere2017"
|
|
|
+literal "true"
|
|
|
+
|
|
|
+\end_inset
|
|
|
+
|
|
|
+
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+Completely reimplement analysis from scratch as a reproducible workflow
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Use newly published methods & algorithms not available during the original
|
|
|
+ analysis: SICER, csaw, MOFA, ComBat, sva, GREAT, and more
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\end_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+SICER, IDR, csaw, & GREAT to call ChIP-seq peaks genome-wide, perform differenti
|
|
|
+al abundance analysis, and relate those peaks to gene expression
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Promoter counts in sliding windows around each gene's highest-expressed
|
|
|
+ TSS to investigate coverage distribution within promoters
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Section*
|
|
|
+Results
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Different histone marks have different effective promoter radii
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+H3K4 and RNA-seq data show clear evidence of naive convergence with memory
|
|
|
+ between days 1 and 5
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Promoter coverage distribution affects gene expression independent of total
|
|
|
+ promoter count
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Remaining analyses to complete:
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+Look for naive-to-memory convergence in H3K27 data
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Look at enriched pathways for day 0 to day 1 (activation) compared to day
|
|
|
+ 1 to day 5 (putative naive-to-memory differentiation)
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Find genes with different expression patterns in naive vs.
|
|
|
+ memory and try to explain the difference with the Day 0 histone mark data
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+Determine whether co-occurrence of H3K4me3 and H3K27me3 (proposed
|
|
|
+\begin_inset Quotes eld
|
|
|
+\end_inset
|
|
|
+
|
|
|
+poised
|
|
|
+\begin_inset Quotes erd
|
|
|
+\end_inset
|
|
|
+
|
|
|
+ state) has effects on post-activation expression dynamics
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Promoter coverage distribution dynamics throughout activation for interesting
|
|
|
+ subsets of genes
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\end_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+(Backup) Compare and contrast behavior of promoter peaks vs intergenic (putative
|
|
|
+ enhancer) peaks (GREAT analysis)
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+Put results in context of important T-cell pathways & gene expression data
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\end_deeper
|
|
|
+\end_deeper
|
|
|
+\begin_layout Section*
|
|
|
+Discussion
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+"Promoter radius" is not constant and must be defined empirically for a
|
|
|
+ given data set
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Evaluate evidence for poised promoters and enhancer effects on gene expression
|
|
|
+ dynamics of naive-to-memory differentiation
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Compare to published work on other epigenetic marks (e.g.
|
|
|
+ chromatin accessibility)
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Chapter*
|
|
|
+2.
|
|
|
+ Improving array-based analyses of transplant rejection by optimizing data
|
|
|
+ preprocessing
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Section*
|
|
|
+Approach
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Machine-learning applications demand a "single-channel" normalization method
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+frozen RMA is a good solution, but not trivial to apply
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Methylation array data preprocessing induces heteroskedasticity
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Need to account for this mean-variance dependency in analysis
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Section*
|
|
|
+Methods
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Expression array normalization for detecting acute rejection
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Use frozen RMA, a single-channel variant of RMA
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Generate custom fRMA normalization vectors for each tissue (biopsy, blood)
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Methylation arrays for differential methylation in rejection vs.
|
|
|
+ healthy transplant
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Adapt voom method originally designed for RNA-seq to model mean-variance
|
|
|
+ dependence
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Use sample precision weighting and sva to adjust for other confounding factors
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Section*
|
|
|
+Results
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+custom fRMA normalization improved cross-validated classifier performance
|
|
|
+
|
|
|
+\begin_inset CommandInset citation
|
|
|
+LatexCommand cite
|
|
|
+key "Kurian2014"
|
|
|
+literal "true"
|
|
|
+
|
|
|
+\end_inset
|
|
|
+
|
|
|
+
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+voom, precision weights, and sva improved model fit
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+Also increased sensitivity for detecting differential methylation
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\end_deeper
|
|
|
+\begin_layout Section*
|
|
|
+Discussion
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+fRMA enables classifying new samples without re-normalizing the entire data
|
|
|
+ set
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+Critical for translating a classifier into clinical practice
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\end_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+Methods like voom designed for RNA-seq can also help with array analysis
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Extracting and modeling confounders common to many features improves model
|
|
|
+ correspondence to known biology
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Chapter*
|
|
|
+3.
|
|
|
+ Globin-blocking for more effective blood RNA-seq analysis in primate animal
|
|
|
+ model
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Standard
|
|
|
+\begin_inset Note Note
|
|
|
+status open
|
|
|
+
|
|
|
+\begin_layout Plain Layout
|
|
|
+Paper title: Optimizing yield of deep RNA sequencing for gene expression
|
|
|
+ profiling by globin reduction of peripheral blood samples from cynomolgus
|
|
|
+ monkeys (Macaca fascicularis).
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\end_inset
|
|
|
+
|
|
|
+
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Standard
|
|
|
+\begin_inset Note Note
|
|
|
+status open
|
|
|
+
|
|
|
+\begin_layout Plain Layout
|
|
|
+How to integrate/credit sections written by others (e.g.
|
|
|
+ wetlab methods)? (Majority of paper text is written by me.)
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\end_inset
|
|
|
+
|
|
|
+
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Standard
|
|
|
+\begin_inset Note Note
|
|
|
+status open
|
|
|
+
|
|
|
+\begin_layout Plain Layout
|
|
|
+Move paper's Background section into thesis Introduction section?
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\end_inset
|
|
|
+
|
|
|
+
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Section*
|
|
|
+Approach
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Cynomolgus monkeys as a model organism
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+Highly related to humans
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Small size and short life cycle - good research animal
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Genomics resources still in development
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\end_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+Inadequacy of existing blood RNA-seq protocols
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+Existing protocols use a separate globin pulldown step, slowing down processing
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\end_deeper
|
|
|
+\begin_layout Section*
|
|
|
+Methods
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+New blood RNA-seq protocol to block reverse transcription of globin genes
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Blood RNA-seq time course after transplants with/without MSC infusion
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Section*
|
|
|
+Results
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+New blood RNA-seq protocol increases effective yield 2-fold while maintaining
|
|
|
+ sample quality (paper)
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+MSC treatment signature is swamped by much larger post-transplant stress/injury
|
|
|
+ response (analysis to demonstrate application of developed protocol to
|
|
|
+ real data)
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Section*
|
|
|
+Discussion
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Globin-blocking is highly effective and efficient for blood RNA-seq
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+More work required to tease out subtle post-transplant MSC signature in
|
|
|
+ living animals
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Part*
|
|
|
+Future Directions
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Study other epigenetic marks in more contexts
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+DNA methylation, histone marks, chromatin accessibility & conformation in
|
|
|
+ CD4 T-cells
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Itemize
|
|
|
+Also look at other types lymphocytes: CD8 T-cells, B-cells, NK cells
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\end_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+Investigate epigenetic regulation of lifespan extension in
|
|
|
+\emph on
|
|
|
+C.
|
|
|
+ elegans
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_deeper
|
|
|
+\begin_layout Itemize
|
|
|
+ChIP-seq of important transcriptional regulators to see how transcriptional
|
|
|
+ drift is prevented
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\end_deeper
|
|
|
+\begin_layout Standard
|
|
|
+\begin_inset ERT
|
|
|
+status open
|
|
|
+
|
|
|
+\begin_layout Plain Layout
|
|
|
+
|
|
|
+% Use "References" instead of "Bibliography"
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Plain Layout
|
|
|
+
|
|
|
+
|
|
|
+\backslash
|
|
|
+renewcommand{
|
|
|
+\backslash
|
|
|
+bibname}{References}
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\end_inset
|
|
|
+
|
|
|
+
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\begin_layout Standard
|
|
|
+\begin_inset CommandInset bibtex
|
|
|
+LatexCommand bibtex
|
|
|
+bibfiles "refs"
|
|
|
+options "plain"
|
|
|
+
|
|
|
+\end_inset
|
|
|
+
|
|
|
+
|
|
|
+\end_layout
|
|
|
+
|
|
|
+\end_body
|
|
|
+\end_document
|